{
  "id": "58efa66070f9fc6f0f000005",
  "type": "summary",
  "question": "Can aspirin be used in cancer prevention?",
  "ideal_answer": "Long-term aspirin use was associated with a modest but significantly reduced risk for overall cancer, especially gastrointestinal tract tumors. Regular aspirin use may prevent a substantial proportion of colorectal cancers and complement the benefits of screening.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/26926089",
    "http://www.ncbi.nlm.nih.gov/pubmed/27817122",
    "http://www.ncbi.nlm.nih.gov/pubmed/27543497",
    "http://www.ncbi.nlm.nih.gov/pubmed/26510933",
    "http://www.ncbi.nlm.nih.gov/pubmed/26712086",
    "http://www.ncbi.nlm.nih.gov/pubmed/27289249",
    "http://www.ncbi.nlm.nih.gov/pubmed/26433247",
    "http://www.ncbi.nlm.nih.gov/pubmed/27268656",
    "http://www.ncbi.nlm.nih.gov/pubmed/26940135"
  ],
  "snippets": [
    {
      "text": " Evidence for an association between aspirin or other nonsteroidal antiinflammatory drug (NSAID) use and basal cell carcinoma (BCC) has been inconsistent.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26433247",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " We report for the first time, in a typical risk US clinical population, a lack of protective association of aspirin for polyps among active smokers. Future prospective studies are recommended to confirm this mitigating effect in order to improve the precision of the growing evidence base about the chemopreventive benefit of aspirin in colorectal cancer.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26510933",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The most serious side effect of prolonged aspirin treatment is haemorrhage, especially from the GI tract. This is likely to be less of a problem with chemoprevention at lower doses. One also needs to consider the impact if aspirin resistance, an increasingly recognised clinical entity.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27289249",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Overall, our results do support the hypothesis that use of NSAIDs or statins may reduce the odds of developing pancreatic cancer.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27817122",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Understanding is growing of the possible mechanisms by which aspirin exerts its anticancer effects. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27543497",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Long-term aspirin use was associated with a modest but significantly reduced risk for overall cancer, especially gastrointestinal tract tumors. Regular aspirin use may prevent a substantial proportion of colorectal cancers and complement the benefits of screening.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26940135",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}